← Back to Search

Other

BI 690517 moderate hepatic impairment (Child-Pugh B) for Liver Disease

Phase 1
Waitlist Available
Research Sponsored by Boehringer Ingelheim
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 4 days
Awards & highlights

Study Summary

This trial tests how mild & moderate liver disease affects drug safety, how it's absorbed & how well it's tolerated.

Eligible Conditions
  • Liver Disease
  • Healthy Subjects

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 4 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 4 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Area under the concentration-time curve of the analyte in plasma over the time interval from 0 extrapolated to infinity (AUC0-∞)
Maximum measured concentration of the analyte in plasma (Cmax)
Secondary outcome measures
Area under the concentration-time curve of the analyte in plasma over the time interval from 0 to the last quantifiable data point (AUC0-tz)

Trial Design

3Treatment groups
Experimental Treatment
Group I: BI 690517 normal hepatic functionExperimental Treatment1 Intervention
control group
Group II: BI 690517 moderate hepatic impairment (Child-Pugh B)Experimental Treatment1 Intervention
Group III: BI 690517 mild hepatic impairment (Child-Pugh A)Experimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
BI 690517
2017
Completed Phase 2
~1040

Find a Location

Logistics

Participation is compensated

You will be compensated for participating in this trial.

Who is running the clinical trial?

IQVIA global CROUNKNOWN
Boehringer IngelheimLead Sponsor
2,515 Previous Clinical Trials
11,347,260 Total Patients Enrolled
~12 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top